EDITORIAL
Published on 25 Sep 2020
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
doi 10.3389/fphar.2020.598858
- 2,803 views
- 8 citations
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
20k
Total Downloads
77k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 27 Sep 2019
Effect Of Dual sEH/COX-2 Inhibition on Allergen-Induced Airway Inflammation
doi 10.3389/fphar.2019.01118
- 3,229 views
- 17 citations
REVIEW
Published on 25 Jun 2019
Epoxy-Oxylipins and Soluble Epoxide Hydrolase Metabolic Pathway as Targets for NSAID-Induced Gastroenteropathy and Inflammation-Associated Carcinogenesis
doi 10.3389/fphar.2019.00731
- 3,957 views
- 24 citations
ORIGINAL RESEARCH
Published on 31 May 2019
Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
doi 10.3389/fphar.2019.00533
- 3,933 views
- 35 citations
ORIGINAL RESEARCH
Published on 29 May 2019
Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver
doi 10.3389/fphar.2019.00580
- 4,133 views
- 5 citations
ORIGINAL RESEARCH
Published on 10 May 2019
Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
doi 10.3389/fphar.2019.00512
- 2,424 views
- 18 citations
ORIGINAL RESEARCH
Published on 08 May 2019
In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
doi 10.3389/fphar.2019.00464
- 4,984 views
- 24 citations
ORIGINAL RESEARCH
Published on 24 Apr 2019
Docosahexaenoic Acid Increases the Potency of Soluble Epoxide Hydrolase Inhibitor in Alleviating Streptozotocin-Induced Alzheimer’s Disease-Like Complications of Diabetes
doi 10.3389/fphar.2019.00288
- 4,173 views
- 21 citations
MINI REVIEW
Published on 24 Apr 2019
Soluble Epoxide Hydrolase Inhibitor: A Novel Potential Therapeutic or Prophylactic Drug for Psychiatric Disorders
doi 10.3389/fphar.2019.00420
- 3,128 views
- 21 citations
ORIGINAL RESEARCH
Published on 20 Mar 2019
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
doi 10.3389/fphar.2019.00263
- 3,950 views
- 21 citations
ORIGINAL RESEARCH
Published on 01 Mar 2019
Epoxyeicosatrienoic Acid-Based Therapy Attenuates the Progression of Postischemic Heart Failure in Normotensive Sprague-Dawley but Not in Hypertensive Ren-2 Transgenic Rats
doi 10.3389/fphar.2019.00159
- 2,421 views
- 15 citations
MINI REVIEW
Published on 07 Feb 2019
Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
doi 10.3389/fphar.2019.00095
- 3,657 views
- 17 citations
Published in
Frontiers in Pharmacology
- Translational Pharmacology
Participating Journals
Frontiers in Physiology
- 3.2 impact factor
- 6.5 citescore
Impact
- 77kTopic views
- 53kArticle views
- 20kArticle downloads